Cargando…
The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5
The gut microbiota plays a crucial role in regulating many physiological systems of the host, including the metabolic and immune system. Disturbances in microbiota composition are increasingly correlated with disease; however, the underlying mechanisms are not well understood. Recent evidence sugges...
Autores principales: | Baars, Annemarie, Oosting, Annemarie, Knol, Jan, Garssen, Johan, van Bergenhenegouwen, Jeroen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023267/ https://www.ncbi.nlm.nih.gov/pubmed/27682110 http://dx.doi.org/10.3390/microorganisms3040641 |
Ejemplares similares
-
Sex differences in lipid metabolism are affected by presence of the gut microbiota
por: Baars, Annemarie, et al.
Publicado: (2018) -
Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
por: Jadhav, Kavita, et al.
Publicado: (2018) -
Blueberry Extract Improves Obesity through Regulation of the Gut Microbiota and Bile Acids via Pathways Involving FXR and TGR5
por: Guo, Jielong, et al.
Publicado: (2019) -
Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
por: Miyata, Sachiho, et al.
Publicado: (2021) -
Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis
por: Han, Bing, et al.
Publicado: (2023)